Vosevi

(sofosbuvir, velpatasvir and voxilaprevir) Gilead

Composition:

• Available in film-coated tablet with each contains 400 mg sofosbuvir, 100 mg velpatasvir and 100 mg voxilaprevir

Indication:

• Indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults

Drug information updated in ‘The Pace’, including formulation, indication, administration and/or presentation being registered or available in Hong Kong within one year prior to the published date is regarded as new.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.